| # | Drug | Count |
|---|---|---|
| 0 | MICONAZOLE NITRATE | 31 |
| 1 | ESTROGENS, CONJUGATED | 25 |
| 2 | CONJUGATED ESTROGENS | 24 |
| 3 | LEVOTHYROXINE SODIUM | 19 |
| 4 | ESTRADIOL | 18 |
| 5 | METHOTREXATE SODIUM | 18 |
| 6 | ADALIMUMAB | 17 |
| 7 | METHOTREXATE | 17 |
| 8 | DAPAGLIFLOZIN | 16 |
| 9 | METFORMIN | 15 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TIOCONAZOLE | 9 | 0.0058 |
| 1 | LACTIC ACID, L-, CITRIC ACID MONOHYDRATE, AND POTASSIUM BITARTRATE | 1 | 0.0055 |
| 2 | CAMPHOR, EUCALYPTUS OIL, MENTHOL | 1 | 0.0043 |
| 3 | AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE | 1 | 0.0042 |
| 4 | FEXOFENADINE HYDROCHLORIDE TABLETS | 1 | 0.0039 |
| 5 | MICONAZOLE NITRATE | 31 | 0.0035 |
| 6 | AMIVANTAMAB AND HYALURONIDASE-LPUJ (HUMAN RECOMBINANT) | 1 | 0.0033 |
| 7 | ESTRADIOL VALERATE AND ESTRADIOL VALERATE/DIENOGEST | 1 | 0.0031 |
| 8 | MEXILETINE HYDROCHLORIDE | 1 | 0.0024 |
| 9 | OSPEMIFENE | 6 | 0.0023 |
| # | Drug class | Count |
|---|---|---|
| 0 | Estrogen [EPC] | 48 |
| 1 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 28 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 27 |
| 3 | Corticosteroid [EPC] | 25 |
| 4 | Azole Antifungal [EPC] | 22 |
| 5 | Progestin [EPC] | 21 |
| 6 | Benzodiazepine [EPC] | 20 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 18 |
| 8 | Tumor Necrosis Factor Blocker [EPC] | 17 |
| 9 | Interleukin-4 Receptor alpha Antagonist [EPC] | 13 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Estrogen Agonist/Antagonist [EPC] | 6 | 0.0023 |
| 1 | Tyrosine Kinase 2 Inhibitor [EPC] | 1 | 0.0003 |
| 2 | Estrogen [EPC] | 48 | 0.0003 |
| 3 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 28 | 0.0003 |
| 4 | Catechol-O-Methyltransferase Inhibitor [EPC] | 1 | 0.0002 |
| 5 | Nitrofuran Antibacterial [EPC] | 3 | 0.0002 |
| 6 | Progesterone [EPC] | 4 | 0.0002 |
| 7 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 4 | 0.0002 |
| 8 | GLP-2 Analog [EPC] | 2 | 0.0001 |
| 9 | beta3-Adrenergic Agonist [EPC] | 7 | 0.0001 |